Regulation of Controlled Substances and Reproductive Health
This Viewpoint reviews the US legal landscape for regulation of drugs with the potential for addiction, the pharmacology of mifepristone and misoprostol, evidence demonstrating their lack of dependency, and the consequences of 2024 policy changes in Louisiana state law.
Authors
- Kimberly K. Scarsi (ORCID: https://orcid.org/0000-0001-9406-693X)
- Julia Tasset (ORCID: https://orcid.org/0000-0002-2713-3239)
- Alison Edelman (ORCID: https://orcid.org/0000-0001-5040-7288)
Institutions
- Oregon Health & Science University (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- JAMA
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1001/jama.2025.0384
- Primary Topic
- Reproductive Health and Contraception
- Type
- article
- Field-Weighted Citation Impact
- 0.00